This cough season, TussiCaps® is available at over 26,000 pharmacies across the US, including Rite Aid®, Walgreens®, Wal-Mart®, Safeway™, and Kroger®.
The wide-scale availability of TussiCaps® represents good news for pharmacists who have been preparing for one of the most challenging cough seasons in history.
Following the Food and Drug Administration's 2007 removal of nearly 200 unapproved cough products containing hydrocodone from the market, pharmacists are preparing for longer-than-normal lines and countless phone calls to local doctors to discuss prescription alternatives.
Having a branded prescription cough treatment in unit-of-use packaging promises to greatly simplify dispensing.
Cover your cough
The Centers for Disease Control and Prevention initiated a campaign called "Cover your Cough" to help reduce the transmission of viruses and bacteria. The focus of the effort is to encourage people to adopt a hands-free technique for covering their mouth when coughing or sneezing. Flyers and posters are available for free download at the CDC web site.
Did you know?
The common cold is the second most common reason for doctors visits and missed days from school and work.
Source: National Center for Health Statistics Dataline. Public Health Reports. 2006. Vol 121.
According to the CDC, 22 million school days are lost annually in the US because of the common cold. Some estimates state that Americans suffer 1 billion colds annually.
The Tussi News Capsule
Want to wise up about the second biggest reason for doctors visits? You've come to the right place.
The Tussi News Capsule condenses the latest information and explores key factors that are shaping the world of cough control. There's even a real-time cough tracker to help you keep tabs on the prevalence of severe cough in your community and around the country.
IMPORTANT RISK INFORMATION
TussiCaps® (hydrocodone polistirex and chlorpheniramine polistirex) extended-release capsules are indicated for relief of cough and upper respiratory symptoms associated with allergy or cold in adults and children 6 years of age and older.
TussiCaps® is contraindicated in the presence of known allergy or sensitivity to hydrocodone or chlorpheniramine. The most common adverse reactions associated with TussiCaps® are sedation, drowsiness, and mental clouding, which may impair the mental and/or physical abilities required for potentially hazardous tasks.
are registered trademarks of Mallinckrodt Inc. TussiCaps logo is a trademark of Mallinckrodt Inc. COVIDIEN and COVIDIEN with Logo are trademarks of Covidien AG.